# Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma

**Authors:** Maryam Soleimani, Marisa Thi, Sajjad Janfaza, Gizem Ozcan, Sylwia Mazurek, Guliz Ozgun, Corinne Maurice-Dror, Bernhard Eigl, Kim Chi, Christian Kollmannsberger, Lucia Nappi

PMC · DOI: 10.1038/s41598-025-99376-z · Scientific Reports · 2025-04-28

## Full-text entities

- **Diseases:** renal cell carcinoma (MESH:D002292)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12037859/full.md

---
Source: https://tomesphere.com/paper/PMC12037859